These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35635649)

  • 1. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
    Jiang Y; Dennis SC; Brewin MP
    Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
    Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
    Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
    de Jel DVC; Disch FJM; Kroon S; Mager JJ; Verdam FJ
    Angiogenesis; 2020 Aug; 23(3):271-274. PubMed ID: 32112177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
    Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
    J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
    Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
    Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
    Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
    Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
    Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
    Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
    Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in epistaxis management: the experience of a dedicated hereditary haemorrhagic telangiectasia clinic.
    Anning R; Huang J; Ronan A; de Malmanche J; Asher R; Low TH
    ANZ J Surg; 2022 Mar; 92(3):499-504. PubMed ID: 34724318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
    Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.
    Pagella F; Pusateri A; Maiorano E; Spinozzi G; Ugolini S; Lizzio R; Mirabella R; Tinelli C; Olivieri C; Matti E
    Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):59-68. PubMed ID: 33746224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
    Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
    Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).
    Al Kadah B; Papaspyrou G; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2015 Jan; 272(1):117-22. PubMed ID: 24854232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia.
    Fiorella ML; Lillo L; Fiorella R
    Acta Otorhinolaryngol Ital; 2012 Jun; 32(3):164-9. PubMed ID: 22767981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
    Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.